04UD3KZ
Supplement Common Iliac Artery, Left to No Qualifier with Nonautologous Tissue Substitute, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 4 Lower Arteries |
| Operation | U Supplement |
| Body Part | D Common Iliac Artery, Left |
| Approach | 3 Percutaneous |
| Device | K Nonautologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures reinforce or augment an artery using additional biological or synthetic material without removing the native vessel segment, distinguishing them from Replacement, where the diseased tissue is excised. In the lower arteries this typically takes the form of patch angioplasty at an endarterectomy site, or endovascular placement of a covered stent graft that lines and reinforces a weakened or aneurysmal segment while the native artery remains in place.
Patients undergo this type of procedure when an artery has been narrowed by plaque removal and needs a widening patch to prevent restenosis, or when an aneurysm needs endoluminal reinforcement rather than open resection. It is common in both open vascular surgery and increasingly in endovascular aneurysm repair, where covered stent grafts are deployed to reinforce the arterial wall from within.
Anatomy & Axis Detail
Common Iliac Artery, Left
The left common iliac artery mirrors its right-sided counterpart, running from the aortic bifurcation to its own division into internal and external iliac branches, and is anatomically situated near the sigmoid colon and left ureter. Supplement procedures on this vessel reinforce a weakened or aneurysmal wall segment, commonly as an extension of aortic aneurysm repair or to correct a residual defect at an endograft's distal landing zone, using synthetic or biologic material applied along the existing arterial wall. Because the left common iliac vein crosses beneath this artery, operative approach and repair technique must account for that adjacent venous structure, and documentation should specify laterality clearly since bilateral common iliac disease is common in diffuse aortoiliac atherosclerosis.
Approach: Percutaneous
Percutaneous describes entry by needle or instrument puncture through the skin or mucous membrane to reach the site of the procedure, without cutting the tissue open or using a visualizing scope. It differs from Open in that the site itself is never exposed, and from Percutaneous Endoscopic in that no endoscope is used to see internal structures. Common examples include needle biopsies and injections.
Device: Nonautologous Tissue Substitute
Nonautologous Tissue Substitute refers to biologic material sourced from a donor or another species, such as an allograft or xenograft, used to replace a body part. It differs from Autologous Tissue Substitute by tissue origin outside the patient's own body, and from Synthetic Substitute by being biologic rather than manufactured material.
Coding & Documentation
Coders should confirm from the operative note that the native artery segment was left in place and that material, whether a bovine pericardial patch, synthetic patch, or covered endograft, was added to reinforce or widen it. The device value must reflect the specific material used, and the body part value should reflect the arterial segment being reinforced, which for endovascular aneurysm repair can span multiple named segments requiring multiple codes.
A frequent error is coding patch angioplasty performed after an endarterectomy as part of the Extirpation code for the plaque removal rather than as a separate Supplement code, when current guidance requires both steps to be captured. Another common mistake is applying Replacement device values to what is actually a reinforcing supplement.